Analysis

Punitives Promise Fiercer Fight In Philly Risperdal Trial

By Matt Fair (January 28, 2019, 9:29 PM EST) -- With the possibility of punitive damages on the table for the first time since trials over breast growth in boys who used the antipsychotic drug Risperdal kicked off in Philadelphia four years ago, experts say that jurors in a case slated to open on Tuesday can expect a heightened level of aggression from counsel on both sides.

The trial set to kick off on Tuesday is the first to go before a jury since the Pennsylvania Superior Court upended an order last year that had barred punitive damages across all of the nearly 7,000 Risperdal-related cases pending against Johnson & Johnson...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!